Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
460,000
-23,000 (-4.76%)
At close: Apr 30, 2026

Hanmi Pharm. Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,832,8985,731,4573,556,8004,473,4213,711,1673,373,870
Market Cap Growth
99.13%61.14%-20.49%20.54%10.00%-23.27%
Enterprise Value
6,238,8856,103,4604,027,0464,935,3544,226,7784,030,879
Last Close Price
460000.00450353.37279478.14349622.87289351.69262307.54
PE Ratio
34.4333.8029.3230.5944.8350.34
Forward PE
31.2533.6419.5430.5738.0144.63
PS Ratio
3.773.702.383.002.792.80
PB Ratio
4.104.032.874.073.683.64
P/TBV Ratio
4.874.783.424.924.514.47
P/FCF Ratio
44.8544.0723.0623.6528.1418.54
P/OCF Ratio
33.7033.1218.3820.6622.8716.71
PEG Ratio
1.421.581.161.082.570.37
EV/Sales Ratio
4.033.942.693.313.173.35
EV/EBITDA Ratio
19.3418.9213.0015.2616.8618.79
EV/EBIT Ratio
27.8727.2618.9521.9527.4732.14
EV/FCF Ratio
47.9746.9326.1126.0932.0522.15
Debt / Equity Ratio
0.310.310.400.520.670.82
Debt / EBITDA Ratio
1.351.351.601.772.713.53
Debt / FCF Ratio
3.343.343.223.035.144.16
Net Debt / Equity Ratio
0.160.160.250.290.440.59
Net Debt / EBITDA Ratio
0.720.720.980.981.762.54
Net Debt / FCF Ratio
1.791.791.971.683.352.99
Asset Turnover
0.740.740.760.780.690.63
Inventory Turnover
2.072.072.302.382.372.04
Quick Ratio
0.900.900.630.610.620.67
Current Ratio
1.481.481.091.041.031.08
Return on Equity (ROE)
14.05%14.05%12.00%15.68%10.48%9.26%
Return on Assets (ROA)
6.73%6.73%6.78%7.35%4.98%4.11%
Return on Invested Capital (ROIC)
12.22%12.26%11.77%13.37%8.83%6.66%
Return on Capital Employed (ROCE)
14.60%14.60%15.90%18.80%12.30%9.70%
Earnings Yield
2.91%2.96%3.41%3.27%2.23%1.99%
FCF Yield
2.23%2.27%4.34%4.23%3.55%5.39%
Payout Ratio
18.20%18.20%10.35%12.31%7.24%8.77%
Buyback Yield / Dilution
-0.07%-0.07%0.08%0.09%0.12%0.11%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.